---
title: "12 Health Care Stocks Moving In Monday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292517298.md"
description: "During Monday's intraday session, several healthcare stocks experienced significant volatility. Top gainers included Agenus (up 95.8%), Q32 Bio (up 81.08%), and Actuate Therapeutics (up 22.31%). Conversely, major losers featured BNB Plus (down 54.9%), Matinas BioPharma Hldgs (down 47.05%), and BioVie (down 27.32%). The report highlights specific price movements and market capitalizations for these listed companies."
datetime: "2026-07-13T17:05:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292517298.md)
  - [en](https://longbridge.com/en/news/292517298.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292517298.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Monday's Intraday Session

### Gainers

-   **Agenus** (NASDAQ:AGEN) shares increased by 95.8% to $6.56 during Monday's regular session. The market value of their outstanding shares is at $139.5 million.
-   **Q32 Bio** (NASDAQ:QTTB) stock rose 81.08% to $20.3. The company's market cap stands at $190.0 million.
-   **Actuate Therapeutics** (NASDAQ:ACTU) stock rose 22.31% to $1.48. The market value of their outstanding shares is at $28.9 million.
-   **Alpha Compute** (NASDAQ:ALP) stock increased by 19.07% to $0.28. The company's market cap stands at $5.6 million.
-   **Accuray** (NASDAQ:ARAY) shares rose 15.08% to $0.28. The company's market cap stands at $28.7 million.
-   **Galectin Therapeutics** (NASDAQ:GALT) stock moved upwards by 14.16% to $4.63. The market value of their outstanding shares is at $267.3 million.

### Losers

-   **BNB Plus** (NASDAQ:BNBX) shares declined by 54.9% to $0.17 during Monday's regular session. The market value of their outstanding shares is at $2.7 million.
-   **Matinas BioPharma Hldgs** (AMEX:MTNB) stock fell 47.05% to $0.4. The company's market cap stands at $4.8 million.
-   **BioVie** (NASDAQ:BIVI) stock decreased by 27.32% to $1.65. The company's market cap stands at $17.1 million.
-   **Bristol-Myers Squibb Company Celegne Contingent Value Rights** (NYSE:CELGR) shares declined by 22.3% to $0.09.
-   **Apollomics** (NASDAQ:APLM) stock fell 20.9% to $14.99. The company's market cap stands at $41.6 million.
-   **Circle8 Group** (NASDAQ:CIRC) shares decreased by 18.03% to $0.7. The market value of their outstanding shares is at $77.3 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [BIVI.US](https://longbridge.com/en/quote/BIVI.US.md)
- [QTTB.US](https://longbridge.com/en/quote/QTTB.US.md)
- [AGEN.US](https://longbridge.com/en/quote/AGEN.US.md)
- [BNBX.US](https://longbridge.com/en/quote/BNBX.US.md)
- [MTNB.US](https://longbridge.com/en/quote/MTNB.US.md)
- [ACTU.US](https://longbridge.com/en/quote/ACTU.US.md)
- [ALP.US](https://longbridge.com/en/quote/ALP.US.md)
- [ARAY.US](https://longbridge.com/en/quote/ARAY.US.md)
- [GALT.US](https://longbridge.com/en/quote/GALT.US.md)
- [APLM.US](https://longbridge.com/en/quote/APLM.US.md)
- [CIRC.US](https://longbridge.com/en/quote/CIRC.US.md)
- [00847G804.US](https://longbridge.com/en/quote/00847G804.US.md)
- [BIVIW.US](https://longbridge.com/en/quote/BIVIW.US.md)
- [APLMW.US](https://longbridge.com/en/quote/APLMW.US.md)

## Related News & Research

- [Agenus posts investor deck spotlighting botensilimab-balstilimab neoadjuvant program in MSS colon cancer](https://longbridge.com/en/news/296536017.md)
- [Agenus extends $24.75 million loan maturity to Nov. 2029 in Ocean 1181 amendment](https://longbridge.com/en/news/296267258.md)
- [US families, healthcare providers under strain after Trump crackdown on Haitian immigrants](https://longbridge.com/en/news/296335867.md)
- [BLS data shows fastest-growing jobs through 2034 led by clean energy, healthcare, and tech](https://longbridge.com/en/news/296263775.md)
- [2,463 Shares in Thermo Fisher Scientific Inc. $TMO Purchased by Alpine Woods Capital Investors LLC](https://longbridge.com/en/news/296447909.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**